Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 01/31/12
Due: 01/31/13
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer | NCT00952497 | ACT Biotech, Inc | user2@example.com | None | 2009-06-30 | 2012-01-31 | 2013-01-31 | - | - | 2025-07-14 |